Compare ONTF & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONTF | RXST |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.2M | 300.5M |
| IPO Year | 2021 | 2021 |
| Metric | ONTF | RXST |
|---|---|---|
| Price | $8.10 | $5.00 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 10 |
| Target Price | $8.10 | ★ $9.78 |
| AVG Volume (30 Days) | ★ 986.7K | 811.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $139,312,000.00 | $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.51 | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.70 | $4.70 |
| 52 Week High | $8.11 | $16.00 |
| Indicator | ONTF | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 67.87 | 33.61 |
| Support Level | $7.84 | N/A |
| Resistance Level | N/A | $7.60 |
| Average True Range (ATR) | 0.02 | 0.33 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 88.89 | 15.57 |
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.